Inhalon launches human challenge trial for RSV treatment
US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...
Virus infection rate rises in UK update as young 'most vulnerable' and NHS advises masks
Hospitals in China have been 'overwhelmed' by outbreak says WHO as NHS says people with respiratory symptoms should 'limit contact with others' ...
Local 12 WKRC Cincinnati16d
Virus spreading in China raises concerns in the United States
Human metapneumovirus is similar to respiratory syncytial virus (RSV) and primarily affects children 5 years old and younger, Sobolewski said. However, adults, especially older adults, can also ...
Portfolio1h
Respiratory season may have peaked in Hungary
Although the number of influenza-like illnesses per 100,000 inhabitants was higher than on the 6th week of 2025 only once in ...
Flu cases continue to rise, RSV and COVID rates decrease nationally: The latest on respiratory virus season for week of Feb. 3
Cases of influenza continue to soar across Canada, meanwhile rates of respiratory syncytial virus, or RSV, and COVID-19 are ...
Cases of 'Chinese mystery virus' on the rise in UK
Cases of a virus that caused concern when it appeared to be spreading widely in parts of China have now risen in the UK. The infection has been identified as Human Metapneumo Virus (HMPV). The virus, ...
Healthshots on MSN13d
Are HMPV and RSV the same? Know more about these respiratory viruses
In the wake of multiple cases of human metapneumovirus (hMPV) in India, multiple questions about its causes and symptoms seem ...
hVIVO wins contract for RSV drug human trial for Inhalon Biopharma
(Alliance News) - hVIVO PLC on Monday said it has signed a contract with Inhalon Biopharma Inc to test its antiviral candidate to treat respiratory syncytial virus. The London-based contract research ...